CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

AHA Advisory Recommends Healthy Eating, Not Just Variety

Published: Fri, 17 Aug 2018 08:09:54 EDT
The advice to 'eat a variety of foods' is outdated because studies show a more varied diet often included more unhealthy foods and was not linked with a healthier weight, an AHA advisory reports.
Medscape Medical News

Study Supports Newest Indication for IL6R Blockade in Giant Cell Arteritis

Published: Fri, 17 Aug 2018 07:45:03 EDT
New research confirms the association of a common variant in the gene that encodes the receptor for IL-6 with reduced risk for aortic aneurysm and supports the newest indication for IL6R blockade, giant cell arteritis.
Medscape Medical News
Displaying results 19-20 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Predicting the risk of heart disease, diabetes and more using millions of gene variants

Published: Mon, 13 Aug 2018 15:45:44 +0000
Scientists led by the Broad Institute have developed a method for scoring disease risk based on data previously generated about five serious conditions and the gene mutations that contribute to them. Among the insights they generated: Up to 25 million Americans face triple the normal risk of coronary artery disease.

Izana starts proof-of-concept trial for spinal arthritis drug

Published: Mon, 13 Aug 2018 13:29:54 +0000
U.K. startup Izana has started recruiting patients into its phase 2a trial of its anti-GM-CSF antibody namilumab in ankylosing spondylitis, a severe form of arthritis affecting the spine.

Fresh from GSK deal, Orchard raises $150M for multifront late-phase gene therapy push

Published: Mon, 13 Aug 2018 10:06:24 +0000
Orchard Therapeutics has raised $150 million (€132 million) to advance three gene therapies toward approval. The series C round continues a transformative year for Orchard defined by the acquisition of GlaxoSmithKline’s portfolio of approved and experimental rare disease gene therapies.
Displaying results 19-21 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

 Security code
1-800-4-the-clinx

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top